YourLawyer.com® 1-800-LAW-INFO (1-800-529-4636)
Parker Waichman Alonso LLP Headlines by Topic
Avandia
FDA Considering Biomarkers As a Way to Improve Drug Safety
Apr 17, 2008 | Parker Waichman Alonso LLP
A new way of testing experimental drugs is being considered by the Food & Drug Administration (FDA). If adopted, the FDA could end up...
FDA Reprimands Glaxo for Avandia Study
Apr 8, 2008 | Parker Waichman Alonso LLP
The US Food and Drug Administration Federal (FDA) has just issued a warning to the drug maker, GlaxoSmithKline, for not reporting safety results on...
More Heat for Vytorin and Avandia
Mar 5, 2008 | Parker Waichman Alonso LLP
Avandia and Vytorin are the subject of yet another government investigation. The Government Accountability Office (GAO) will look into whether...
Avandia Woes Mean Cutbacks at GlaxoSmithKline
Feb 19, 2008
Avandia problems continue to hurt GlaxoSmithKline’s bottom line, as the Avandia maker announced this week that it would be giving up more than...
First Avandia Lawsuits Filed, Many More Expected
Feb 18, 2008 | Parker Waichman Alonso LLP
Avandia lawsuits against GlaxoSmithKline over the drugs alleged cardiac side effects are beginning to make their way through the courts, and...
Avandia Study Leaked by Glaxo-Paid Reviewer
Jan 31, 2008 | Parker Waichman Alonso LLP
The Avandia study that touched off a firestorm over the diabetes drug’s cardiac side effects was leaked to GlaxoSmithKline ahead of its...
Avandia Defects Could be Responsible for 83,000 Excess Heart Attacks
Jan 10, 2008 | Parker Waichman Alonso LLP
Avandia could have been responsible for an additional 83,000 heart attacks. That stunning number comes from an Avandia analysis performed by...
GlaxoSmithKline, AstraZeneca at Center of Iraq Bribe Probe in Britain
Jan 2, 2008 | Parker Waichman Alonso LLP
GlaxoSmthKline, the maker of Avandia, and AstraZeneca, another large drug maker, are being investigated in Britain for allegedly bribing the regime...
Avandia Heart Attacks, Other Cardiac Problems Now Being Seen in General Patient Population
Dec 17, 2007 | Parker Waichman Alonso LLP
The consequences of deadly Avandia side-effects are now being seen in the general population, a new study has found. Previously, evidence that...
Older Avandia Patients Have Higher Rates of Heart Attacks, Death
Dec 12, 2007 | Parker Waichman Alonso LLP
Avandia puts older patients at a significantly higher risk of heart attack and death, says a new study. The research, conducted by the...
Avandia
